Sun Pharma

11.03.2025 • News

Sun Pharma to Acquire Checkpoint Therapeutics

Indian generic drug maker Sun Pharma agreed to acquire US immunotherapy and targeted oncology company Checkpoint Therapeutics for an upfront value of $355 million. The transaction is expected to be completed in the second quarter of 2025 and is subject to customary closing conditions.

07.06.2016 • News

Sun Pharma Sells US Plants to Frontida

04.04.2016 • News

Sun Pharma Buys Novartis Drugs

15.02.2016 • News

Mylan to Buy Sweden’s Meda for $9.9 Billion

12.06.2013 • News

Teva, Sun Pharma to Pay $2.15 Billion to Settle Pfizer Patent Suit

01.06.2013 • News

India's Sun Pharma in Talks to Buy Sweden's Meda for $5-$6 Billion

13.08.2012 • News

India's Sun Pharma Wins over Taro with Higher Offer

12.04.2011 • News

India's Sun Pharma, US Merck in Generics Joint Venture

Top-Feature

IMCD Deutschland GmbH

Fostering Innovation and Collaboration

Digitalization in the chemical industry

Evonik Industries AG

Maximize the Potential of Spent Hydroprocessing Catalysts

Ecocool GmbH

Transport Logistic: Ecocool Presents Packaging Solutions for Pharmaceutical Transports

Innovation Pitch

Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.